Clinical trial intelligence that helps match a patient's disease profile to promising treatment options.
Consented intake · your records travel with you · nothing moves without your sign-off
Citeline works in the clinical trials space, supporting biomarker-drug matching. Based on the disease profile in a patient's test data, it helps identify the treatment options with the most likely effective response. It is for patients and care teams seeking the best treatment ideas from global evidence, along with predictions of treatment response and confidence in the expected outcome.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Citeline (clinical trials) handles billing.
We don't have confirmed insurance details for Citeline (clinical trials) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Citeline's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Identify the best treatment ideas using the best global thinking, predict best treatment response
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.